The search strategy targeted studies involving GLP-1 receptor agonists (e.g., exenatide, liraglutide, dulaglutide, lixisenatide, benaglutide, loxenatide, semaglutide) and multi-target receptor agonists (e.g., tirzepatide), focusing on gastrointestinal adverse events (e.g., nausea, vomiting, diarrhea, constipation, dyspepsia, and reduced appetite) in patients with type 2 diabetes mellitus (T2DM) (Supplementary Material)
PubChem Reference: View compound profile on NIH PubChem Key Characteristics MOLECULAR PROFILE Formula: C 50 H 69 N 15 O 9 Weight: 1024.20 g/mol CAS: 121062-08-6 Structure: Cyclic heptapeptide with lactam bridge PHYSICAL PROPERTIES Form: White to off-white lyophilized powder Solubility: Soluble in water and acetic acid Selectivity: Non-selective MC1R/3R/4R/5R agonist Storage: Keep refrigerated 3646 F (28 C) Related products TB-500 $60.00 $90.00Price range: $60.00 through $90.00
Others may be too aggressive for sensitive or pigment-unstable skin
Injection vs pill Wegovy is currently available in two forms, and understanding the difference matters when considering whether its the right fit
Sun Y, Wang X, Zhou Y, Zhang J, Cui W, Wang E, Du J, Wei B, Xu X (2021) Protective effect of metformin on BPA-induced liver toxicity in rats through upregulation of cystathionine synthase and cystathionine lyase expression
293, E128995 (2007)
.jpg?rev=4ff38a34a0554f04b4485901068d755b)
